Hospital Medicine & Internal Medicine: A Clinical Update - Hybrid Event

Hospital Medicine & Internal Medicine: A Clinical Update is organized by American Medical Seminars (AMS), Inc. and will be held from Dec 12 - 15, 2022 at Lido Beach Resort, Sarasota, Florida, United States of America.

Agenda & Learning Objectives:
Day 1:
Practical Approach to the Diagnosis and Management of Heart Failure. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Appraise the symptoms of congestive heart failure and detect the common causes of systolic heart failure.
• Employ the current standard-of-care therapies.
• Determine which patients will benefit from device therapy and specify when to refer patients for more advanced cardiac care.
• Be familiar with, and be able to apply, the 2013 ACCF/AHA Guidelines for the Management of Heart Failure.
Strategies to Address the Issue of Preventable Hospital Readmissions.   
Upon completion of this session, the participant should be able to: EBM,COMP
• Identify the factors which contribute to increase risk of readmission.
• Stratify the risk for readmission utilizing evidence-based tools.
• Develop a transition of care strategy to reduce the likelihood of a preventable readmission.
Prevention of Type 2 Diabetes. 
Upon completion of this session, the participant should be able to: GL,COMP
• Recognize patients with pre-diabetes.
• Employ current Guidelines and recommendations of the ADA regarding diabetes prevention.
• Treat CVD risk factors in patients with pre-diabetes.
Treatment of Hyperglycemia in Type 2 Diabetes. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Understand the glucose targets in T2DM.
• 2Employ the current ADA Guidelines for pharmacological therapy.
• Develop individualized therapeutic regimens to optimize glycemic control.
Common Endocrine Disorders. 
Upon completion of this session, the participant should be able to: COMP
• Recognize, evaluate and treat common endocrine abnormalities and employ Endo Society Guidelines to include: Hypoglycemia, Hypercalcemia, Low testosterone, Adrenal masses.

Day 2:
Approach to the Management of Chest Pain. 
Upon completion of this session, the participant should be able to: GL,COMP
• Evaluate the complaint in the context of history, physical exam, and EKG findings.
• Develop a strategy to use cardiac biomarkers in the evaluation of ACS.
• Use recent research studies and guidelines to develop an approach to the patient with chest pain.
Practical Approach to the Patient with Potential DVT.   
Upon completion of this session, the participant should be able to: GL,COMP
• Obtain an appropriate medical history to better identify those patients at risk.
• More confidently evaluate and assess the patient suspected of having DVT.
• Better manage patients with the confirmed diagnosis of DVT.
Practical Approach to the Patient with Hyperlipidemia. 
Upon completion of this session, the participant should be able to: GL,COMP
• Apply the current NCEP guidelines.
• Develop a practical approach for considering the new medications available.
• Consider the new targets developed for cholesterol end point.
Diabetes/Endocrine Cases. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Appraise key issues and develop a treatment plan, employing the ADA and ATA Guidelines, for challenging diabetes and endocrine cases.
Thyroid Disease. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Individualize evaluation and management options for hypothyroidism.
• Review evaluation and treatment options for hyperthyroidism.
• Review current guidelines describing the evaluation and management of thyroid nodules.

Day 3:
Diagnosis of Primary Headache Syndromes. 
Upon completion of this session, the participant should be able to: COMP
• Distinguish among the historical features of migraine, tension-type, and cluster headaches.
• Recognize which historical features best discriminate between migraine and tension-type headaches.
• Apply the triggers for migraine to lifestyle modification.
Treatment of Primary Headache Syndromes.   
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Appreciate the role of abortive therapy for migraine, tension-type, and cluster headaches.
• Recognize the range of options for pharmacologic acute and preventive therapy, as recommended by the AHS 2015 Evidence-Based recommendations for migraine, as well as options for tension-type, and cluster headaches.
• Develop non-pharmacologic treatment strategies for migraine as per the most recent Cochrane Systematic Review.
Hospital Delirium. 
Upon completion of this session, the participant should be able to: COMP
• Interpret changes in the updated 2012 American College of Chest Physicians Evidence-Based Guidelines for Antithrombotic Therapy.
• Assess restrictive red blood cell transfusion strategy as recommended by American Association of Blood Banks (AABB) guidelines.
• Evaluate clinical factors that make patients more prone to hospital and postoperative delirium.
• Employ evidence-based strategies to treat delirium in hospitalized patients.
Update in Perioperative Medicine. 
Upon completion of this session, the participant should be able to: COMP
• Appraise pre-operative cardiac risk stratification and management strategies, as per the ACC/AHA Risk Clinical Predictors.
• Determine the role of non-invasive stress testing, echocardiography, coronary angiography and the use of biomarkers to assess peri-operative cardiac risk, as per the ACC/AHA (2014) Perioperative CV Evaluation Guidelines.
• Relate the indications for beta blockers, statins and aspirin in the peri-operative period.
• Evaluate the bleeding risks of commonly prescribed medications and OTC supplements taken pre-operatively.
Rational Management of Depression in Primary Care. 
Upon completion of this session, the participant should be able to: COMP
• Employ an appropriate initial approach to use of the updated USPSTF Guidelines for screening of the patient with depression.
• Determine the proper role of second generation antidepressants as per the ACP Guideline.
• Assess the effectiveness of augmentation and switching strategies.
• Specify the most common side effects, as per the 2016 ACP Guidelines, of commonly used antidepressants.

Day 4:
Challenging Infections: MRSA and C. difficile. 
Upon completion of this session, the participant should be able to: GL,COMP
• Assess and apply appropriate treatment strategies for different types of methicillin resistant staph aureus infections.
• Employ rational use and relate the precautions of newer antibiotics when treating resistant bacteria.
• Distinguish Guideline based treatment of Clostridium difficile infections.
Cirrhosis.   
Upon completion of this session, the participant should be able to: EBM,COMP
• Apply evidence based treatments for common manifestations of cirrhosis, including ascites, spontaneous bacterial peritonitis, esophageal variceal bleed, and hepatic encephalopathy.
• Evaluate prognostic scoring systems for alcoholic cirrhosis.
• Apply evidence based treatments for hepatorenal syndrome.
Atrial Fibrillation in the Hospitalized Patient. 
Upon completion of this session, the participant should be able to: GL,COMP
• Assess and evaluate treatment options for atrial fibrillation with rapid ventricular response, as per the 2010 HFSA Guidelines.
• Employ appropriate anticoagulation strategies for atrial fibrillation.
• Distinguish the advantages of rhythm versus rate control treatment strategies, 2014 ACC/AHA Guidelines for atrial fibrillation management.
• Determine the possible underlying causes of CHF exacerbations.
New Drugs for the Primary Care Physician: What You Need to Know. 
Upon completion of this session, the participant should be able to: COMP
• Survey important advances in pharmacotherapy that pertain to primary care practice.
• Discuss the efficacy and list the side effects for each drug.
• Differentiate key new drugs with previously available medications for similar indications.
Hypertension: Recent Trials and Rational Therapy. 
Upon completion of this session, the participant should be able to: GL,COMP
• Appreciate that all antihypertensive medications do not equally reduce cardiovascular risk.
• Apply the current JNC guidelines to clinical care of hypertensive patients.
• Recognize compelling indications for selection of initial antihypertensive therapy.
• Identify which drugs most effectively reduce the risk of cardiovascular disease.